BackKindred Biosciences Overview

Kindred Biosciences Research & Development

Research & Development expenses for KIN.

Quarterly R&D Expenses

$5.57M
↓ 24.67% YoY

As of Jun 30, 2021

Annual R&D Expenses (TTM)

$26.88M
↓ 12.42% YoY

Trailing 12 months ending Jun 30, 2021

Average R&D Expenses (Comparison Companies)

Research & Development History

Research & Development Comparison

Annual Research & Development Growth Rate (%)

Annual Research & Development Growth (Absolute)

Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin